BioPharma Dive 24 avr. 2026 Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
BioPharma Dive 17 avr. 2026 Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool
BioPharma Dive 8 avr. 2026 Novo underprices Lilly with higher-dose Wegovy; Insmed absorbs ‘expected’ study failure
BioPharma Dive 12 mars 2026 Lilly warns GLP-1 knockoffs may be ‘dangerous,’ escalating war with compounders
BioPharma Dive 23 févr. 2026 Novo’s next-gen obesity shot fails to match Lilly drug in head-to-head study
BioPharma Dive 9 févr. 2026 Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals
BioPharma Dive 4 févr. 2026 Lilly soars again as fast-selling weight loss drugs top Wall Street projections